Galderma Group Ltd header image

Galderma Group Ltd

GALD

Equity

ISIN CH1335392721 / Valor 133539272

SIX Swiss Exchange (2025-10-21)

CHF 137.40-0.72%

Galderma Group Ltd
UMushroom community rating:

4.33 3 votes No rating yet

NegativeNeutralPositive

About company

Galderma Group Ltd is a leading company in the dermatology sector, focusing exclusively on this field for over 40 years. The company specializes in developing, manufacturing, and marketing a wide range of dermatological treatments and solutions. Galderma's product portfolio includes therapeutic dermatology products, dermatological skincare, and injectable aesthetic treatments, catering to a diverse range of skin health needs. With a global presence, the company operates research and development centers and manufacturing facilities strategically located around the world. Galderma is dedicated to advancing the field of dermatology through continuous innovation and science-based solutions, aiming to enhance the quality of life for patients with various skin conditions.

Summarized from source with an LLMView SourceSector: Healthcare

Latest Results ():

Summarized from source with an LLMView Source

Key figures

75.7%1Y

%3Y

%5Y

Performance

34.6%1Y

31.7%3Y

31.7%5Y

Volatility

40487 M

Market cap (USD)

145,935

Daily traded volume (Shares)

100.6 / 98.35

1 day high/low (USD)

0.00 / 0.00

52 weeks high/low (USD)

01 January, 2022

Dividend ex-date

0.00

Dividend (USD)

0.00%

Dividend yield (p.a.)

0.002022

0.002023

0.002024

Est dividend (USD)

0.00%2022

0.00%2023

0.00%2024

Est dividend yield

10.00

P/E ratio

00.002022

00.002023

00.002024

Est P/E ratio

0.00

EPS (USD)

0.002022

0.002023

0.002024

Est EPS (USD)

Ratings & reviews

4.33

3 votes

Performance:

4.00

Innovation:

4.00

Society:

3.00

Nature:

2.67

Laura Bischofberger

Switzerland, 12 Jun 2024

New kid on the block, lets see where they go after they IPO.

Hein Sweerts de Landas

Switzerland, 12 Jun 2024

It's the trend, personal beautification. Online: photoshop, real world: Galderma!

Lea Katunaric

Switzerland, 12 Jun 2024

Was never too keen on this type of procedures.

EQUITIES OF THE SAME SECTOR

Roche Holding Ltd

Roche Holding Ltd Valor: 1203204

Annual Return

-50%0%+50%

Risk level

110

-0.11%CHF 279.50

Heidelberg Pharma AG

Heidelberg Pharma AG Valor: 24937540

Annual Return

-50%0%+50%

Risk level

110

-0.34%EUR 2.93

Viking Therapeutics Inc

Viking Therapeutics Inc Valor: 24839858

Annual Return

-50%0%+50%

Risk level

110

-2.28%USD 32.98

Merit Medical Systems Inc

Merit Medical Systems Inc Valor: 951136

Annual Return

-50%0%+50%

Risk level

110

1.13%USD 84.15

Surgery Partners Inc

Surgery Partners Inc Valor: 29308003

Annual Return

-50%0%+50%

Risk level

110

1.01%USD 21.06

Olaplex Holdings Inc

Olaplex Holdings Inc Valor: 113471584

Annual Return

-50%0%+50%

Risk level

110

-4.10%USD 1.17

Nelnet Inc

Nelnet Inc Valor: 1665235

Annual Return

-50%0%+50%

Risk level

110

-0.84%USD 129.98

Draegerwerk AG & Co. KGaA

Draegerwerk AG & Co. KGaA Valor: 330446

Annual Return

-50%0%+50%

Risk level

110

-0.78%EUR 76.60

AtriCure Inc

AtriCure Inc Valor: 2134051

Annual Return

-50%0%+50%

Risk level

110

-1.23%USD 37.00

Amicus Therapeutics Inc

Amicus Therapeutics Inc Valor: 2644388

Annual Return

-50%0%+50%

Risk level

110

0.36%USD 8.47

SIX

FactSet

Clearbit

Logos provided by Clearbit